<DOC>
	<DOCNO>NCT00225433</DOCNO>
	<brief_summary>In vitro fertilization ( IVF ) common procedure use assist couple difficulty conceive pregnancy . IVF process oocyte ( egg ) retrieve woman 's ovary fertilize sperm laboratory . In order maximize number oocytes retrieve , woman undergo ovarian stimulation recombinant follicle stimulate hormone ( FSH ) . Typically 6-20 oocyte retrieve , case limit response stimulation , produce limited number oocyte . This call poor ovarian response . This study design objectively compare two treatment regimen currently advocate clinical practice , never compare directly . The purpose ass ovarian response start treatment end precede cycle may increase number develop oocyte .</brief_summary>
	<brief_title>Luteal Phase FSH IVF Poor Responder</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>1 . Infertile woman plan undergo IVF 2 . Poor ovarian response mostrecent previous IVF cycle within past 18 month define follow criterion : A ) &lt; 5 dominant follicle day hCG , B ) &lt; 5 oocyte retrieve , C ) cancellation previous IVF cycle due poor response ovulation stimulation . 3 . Aged 2042 ( inclusive ) time randomization 4 . Presence ovaries 5 . Normal pap smear within past three year 6 . At least 45 day last IVF cycle 7 . Be willing able comply protocol duration study 8 . Have give write informed consent , prior studyrelated procedure , part normal medical care , understand consent may withdraw patient time without prejudice future medical care . 1 . Clinically significant systemic disease 2 . Current regular cigarette smoking patient report 3 . Known positive Human Immunodeficiency Virus 4 . Any medical condition , judgment investigator sponsor , may interfere absorption , distribution , metabolism excretion medication use 5 . Abnormal , undiagnosed gynecological bleeding 6 . Known allergy hypersensitivity human gonadotropin preparation 7 . Simultaneous participation another investigational drug device trial 8 . Subject fails , 2 separate menstrual cycle attempt , FSH â‰¤12.0 ultrasound exam within normal limit ( per standard IVF ) Baseline Visit 9 . For subject randomize Luteal Phase Regimen , failure ovulate 2 separate menstrual cycle attempt , evidence ovulation predictor kit , progesterone level , /or visualization corpus luteum cyst ovary ultrasound exam Luteal Visit</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>infertility</keyword>
	<keyword>vitro fertilization</keyword>
</DOC>